Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,844 | -63,057 | -44,464 | -31,560 | -46,277 |
| Depreciation Amortization | 152 | 587 | 464 | 351 | 637 |
| Accounts receivable | -3,010 | 37,792 | 37,629 | 40,352 | N/A |
| Accounts payable and accrued liabilities | -4,158 | 3,307 | 1,341 | -452 | N/A |
| Other Working Capital | -10,407 | 53,416 | 41,378 | 42,197 | 23,956 |
| Other Operating Activity | 10,977 | -22,687 | -24,777 | -31,406 | 7,848 |
| Operating Cash Flow | $-19,290 | $9,359 | $11,570 | $19,483 | $-13,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -1,803 | -1,007 | -633 | -652 |
| Purchase Of Investment | N/A | 13,751 | 6,420 | 3 | N/A |
| Purchase Sale Intangibles | N/A | -32 | N/A | N/A | N/A |
| Other Investing Activity | 3 | -18 | 10 | 3 | 13,002 |
| Investing Cash Flow | $-68 | $11,930 | $5,424 | $-628 | $12,350 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 42,521 | 39,703 | 43,195 | N/A |
| Other Financing Activity | -63 | -290 | -270 | -861 | 19,810 |
| Financing Cash Flow | $-63 | $42,231 | $39,433 | $42,334 | $19,810 |
| Exchange Rate Effect | 311 | -144 | 95 | 20 | -431 |
| Beginning Cash Position | 98,672 | 37,745 | 35,245 | 38,368 | 17,353 |
| End Cash Position | 79,562 | 101,121 | 91,766 | 99,577 | 35,245 |
| Net Cash Flow | $-19,110 | $63,376 | $56,522 | $61,209 | $17,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,290 | 9,359 | 11,570 | 19,483 | -13,836 |
| Capital Expenditure | -71 | -1,803 | -1,007 | -633 | N/A |
| Free Cash Flow | -19,361 | 7,556 | 10,563 | 18,849 | -13,836 |